Hemangiosarcoma is an aggressive cancer in dogs that often presents late and requires careful end-of-life welfare decisions from owners and veterinarians.
Hemangiosarcoma confronts owners and veterinarians with profound welfare decisions. The disease's aggressive nature means that even with treatment, survival is measured in months. Decisions about surgery, chemotherapy, and the point of transition to palliative care require careful quality of life assessment. Dogs' inability to communicate their experience makes these decisions especially difficult. Signs of poor quality of life — persistent pain, inability to eat, loss of interest in normal activities — should prompt serious discussion of humane euthanasia. The veterinary profession increasingly supports structured quality of life assessment tools to help owners navigate these decisions. Early conversations about prognosis and goals of care prevent crisis decision-making.